US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Monte Rosa Therapeutics

13.38

-0.9400-6.56%

Post-market: 13.380.00000.00%19:30 EDT

Volume:884.65K

Turnover:12.09M

Market Cap:1.14B

PE:-7.67

High:14.30

Open:14.29

Low:13.37

Close:14.32

52wk High:25.77

52wk Low:4.60

Shares:85.31M

Float Shares:54.48M

Volume Ratio:0.72

T/O Rate:1.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7450

EPS(LYR):-0.4650

ROE:-42.66%

ROA:-21.63%

PB:2.34

PE(LYR):-28.78

Loading ...

Overview Company News Filings

Monte Rosa Therapeutics (GLUE) Looks Pricey As Phase 2 Progress Keeps The Story Alive

Simply Wall St.

Monte Rosa Therapeutics Price Target Maintained with a $28.00/Share by Guggenheim

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Rhythm Pharmaceuticals (RYTM)

Monte Rosa Doses First Patient in Phase 2 MODeFIRe-1 Trial of MRT-2359 Plus Apalutamide in mCRPC

Monte Rosa Therapeutics Announces First Patient Dosed in Modefire-1, a Phase 2 Study of Mrt-2359 in Combination with Apalutamide in Patients with Ar Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

THOMSON REUTERS

Monte Rosa Therapeutics - to Provide Phase 1/2 Study Update on Mrt-2359 Plus Enzalutamide by Year-End

THOMSON REUTERS

Widening Losses And Profitability Swing Might Change The Case For Investing In Monte Rosa Therapeutics (GLUE)

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)

Monte Rosa Therapeutics is Maintained at Overweight by Wells Fargo

Gyre Therapeutics Q2 Revenue Beats Estimates on Higher Etuary Sales Volumes

Relay Therapeutics Q2 Revenue Misses Estimates on Higher R&D Expenses; Net Loss Widens

Monte Rosa Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Monte Rosa Therapeutics Q2 EPS $(0.43) Misses $(0.38) Estimate, Sales $8.968M Beat $5.524M Estimate

Benzinga Earnings

Monte Rosa Publishes Corporate Presentation on Targeted Protein Degradation Pipeline and Molecular Glue Degraders

Monte Rosa Activates Phase 2 MODeFIRe-1 Trial of MRT-2359 Plus Apalutamide in Metastatic Prostate Cancer

Monte Rosa Q2 FY26 Net Loss Widens to $43.4 Million; Revenue Falls 61.3% to $9 Million

Monte Rosa Therapeutics Q2 Operating Expenses USD 58.098 Million

THOMSON REUTERS

Monte Rosa’s MODeFIRe-1 Trial Pushes GLUE Into a Key Mid-Stage Prostate Cancer Test

Monte Rosa Therapeutics is Maintained at Outperform by Wedbush

Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/GLUE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLUE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLUE\",,,,,undefined,":{"symbol":"GLUE","market":"US","secType":"STK","nameCN":"Monte Rosa Therapeutics","latestPrice":13.38,"timestamp":1787947200000,"preClose":14.32,"halted":0,"volume":884651,"hourTrading":{"tag":"盘后","latestPrice":13.38,"preClose":13.38,"latestTime":"19:30 EDT","volume":18129,"amount":242675.12,"timestamp":1787959804975,"change":0,"changeRate":0,"amplitude":0.003737},"delay":0,"changeRate":-0.06564245810055862,"floatShares":54476100,"shares":85313401,"eps":-1.744998,"marketStatus":"Market Closed","change":-0.94,"latestTime":"08-28 16:00:00 EDT","open":14.29,"high":14.3,"low":13.37,"amount":12090413.750974,"amplitude":0.064944,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.744998,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"listingDate":1624507200000,"exchange":"NASDAQ","adjPreClose":14.32,"preHourTrading":{"tag":"盘前","latestPrice":14.26,"preClose":14.32,"latestTime":"09:29 EDT","volume":147,"amount":2099.130159,"timestamp":1787923799999,"change":-0.06,"changeRate":-0.00419,"amplitude":0.086592},"postHourTrading":{"tag":"盘后","latestPrice":13.38,"preClose":13.38,"latestTime":"19:30 EDT","volume":18129,"amount":242675.12,"timestamp":1787959804975,"change":0,"changeRate":0,"amplitude":0.003737},"volumeRatio":0.7197382405437343,"impliedVol":1.3178,"impliedVolPercentile":0.8645},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLUE\",,,,,undefined,":{"symbol":"GLUE","floatShares":54476100,"roa":"-21.63%","roe":"-42.66%","lyrEps":-0.464974,"volumeRatio":0.7197382405437343,"shares":85313401,"dividePrice":0,"high":14.3,"amplitude":0.064944,"preClose":14.32,"low":13.37,"week52Low":4.6,"pbRate":"2.34","psRate":"39.74","week52High":25.77,"institutionHeld":0,"latestPrice":13.38,"eps":-1.744998,"divideRate":0,"volume":884651,"delay":0,"ttmEps":-1.744998,"open":14.29,"prevYearClose":15.68,"prevWeekClose":14.3,"prevMonthClose":16.52,"prevQuarterClose":24.2,"fiveDayClose":14.3,"twentyDayClose":16.52,"sixtyDayClose":17.59},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLUE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"GLUE","fiscalQuarterEnding":"2026/06","expectedEps":-0.25,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.43},{"market":"US","date":"2026-05-07","symbol":"GLUE","fiscalQuarterEnding":"2026/03","expectedEps":-0.28,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2026-03-17","symbol":"GLUE","fiscalQuarterEnding":"2025/12","expectedEps":-0.47,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773720000000,"reportTimeType":"pre","actualEps":-0.55},{"market":"US","date":"2025-11-06","symbol":"GLUE","fiscalQuarterEnding":"2025/09","expectedEps":-0.39,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2025-08-07","symbol":"GLUE","fiscalQuarterEnding":"2025/06","expectedEps":-0.31,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLUE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLUE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1765944000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLUE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLUE","date":"2026-08-28","current":-7.667631,"percent":0.217496,"low":-43.461106,"twenty":-8.243561,"median":-3.118402,"eighty":-1.583646,"high":92.408827,"avg":2.313362,"sd":22.694937,"marketCap":1221687902},"quantilePoints":[{"date":"2021-09-03","current":-33.404953,"twenty":-29.94654,"median":-23.831326,"eighty":-19.992342,"marketCap":1900541423},{"date":"2021-09-10","current":-27.62774,"twenty":-29.970282,"median":-25.514705,"eighty":-20.114086,"marketCap":1571852667},{"date":"2021-09-17","current":-24.319692,"twenty":-29.865817,"median":-25.514705,"eighty":-20.164812,"marketCap":1383644585},{"date":"2021-09-24","current":-18.898609,"twenty":-29.783512,"median":-24.876293,"eighty":-19.760379,"marketCap":1075217465},{"date":"2021-10-01","current":-15.883379,"twenty":-29.531847,"median":-23.770454,"eighty":-19.525168,"marketCap":903668949},{"date":"2021-10-08","current":-14.078989,"twenty":-29.036431,"median":-23.151591,"eighty":-19.353,"marketCap":801009996},{"date":"2021-10-15","current":-16.77766,"twenty":-28.21021,"median":-22.63418,"eighty":-19.085351,"marketCap":954548168},{"date":"2021-10-22","current":-18.059726,"twenty":-28.061007,"median":-22.482,"eighty":-18.846594,"marketCap":1027490056},{"date":"2021-10-29","current":-18.558307,"twenty":-27.994851,"median":-21.655158,"eighty":-18.811555,"marketCap":1055856346},{"date":"2021-11-05","current":-20.03031,"twenty":-27.843001,"median":-21.486484,"eighty":-18.846594,"marketCap":1139604440},{"date":"2021-11-12","current":-16.693989,"twenty":-27.653065,"median":-20.857321,"eighty":-18.476002,"marketCap":1171483973},{"date":"2021-11-19","current":-12.969486,"twenty":-27.523275,"median":-20.489321,"eighty":-17.88087,"marketCap":910120736},{"date":"2021-11-26","current":-13.618955,"twenty":-27.105417,"median":-20.138434,"eighty":-17.339553,"marketCap":955696532},{"date":"2021-12-03","current":-10.789128,"twenty":-26.765116,"median":-20.069154,"eighty":-16.316237,"marketCap":757116279},{"date":"2021-12-10","current":-11.630786,"twenty":-26.638492,"median":-19.721664,"eighty":-15.543077,"marketCap":816178790},{"date":"2021-12-17","current":-12.286882,"twenty":-26.33776,"median":-19.590588,"eighty":-15.13155,"marketCap":862219645},{"date":"2021-12-23","current":-13.877417,"twenty":-26.23013,"median":-19.533563,"eighty":-14.4214,"marketCap":973833839},{"date":"2021-12-31","current":-13.532801,"twenty":-26.075047,"median":-19.397827,"eighty":-13.804517,"marketCap":949650763},{"date":"2022-01-07","current":-11.299425,"twenty":-25.905269,"median":-19.308938,"eighty":-13.408209,"marketCap":792925833},{"date":"2022-01-14","current":-9.940843,"twenty":-25.674568,"median":-19.134049,"eighty":-12.966835,"marketCap":697588710},{"date":"2022-01-21","current":-8.482853,"twenty":-25.559023,"median":-19.073177,"eighty":-12.738859,"marketCap":595275699},{"date":"2022-01-28","current":-7.111016,"twenty":-25.514705,"median":-18.879368,"eighty":-12.278929,"marketCap":499008457},{"date":"2022-02-04","current":-8.529243,"twenty":-25.253544,"median":-18.803641,"eighty":-11.885272,"marketCap":598531113},{"date":"2022-02-11","current":-8.648533,"twenty":-24.95755,"median":-18.447512,"eighty":-11.670549,"marketCap":606902177},{"date":"2022-02-18","current":-9.013031,"twenty":-24.542332,"median":-17.925188,"eighty":-11.445224,"marketCap":632480430},{"date":"2022-02-25","current":-9.993861,"twenty":-24.124346,"median":-17.632371,"eighty":-11.211945,"marketCap":701309183},{"date":"2022-03-04","current":-8.641906,"twenty":-23.782629,"median":-17.299983,"eighty":-10.530666,"marketCap":606437118},{"date":"2022-03-11","current":-9.463682,"twenty":-23.559432,"median":-16.693989,"eighty":-9.96205,"marketCap":664104451},{"date":"2022-03-18","current":-9.258238,"twenty":-23.26116,"median":-16.061443,"eighty":-9.601529,"marketCap":649687618},{"date":"2022-03-25","current":-7.43575,"twenty":-23.102893,"median":-15.543077,"eighty":-9.474286,"marketCap":521796355},{"date":"2022-04-01","current":-9.229506,"twenty":-22.899987,"median":-15.21083,"eighty":-9.343067,"marketCap":682595781},{"date":"2022-04-08","current":-8.094628,"twenty":-22.648383,"median":-15.110081,"eighty":-9.247635,"marketCap":598662468},{"date":"2022-04-14","current":-8.571151,"twenty":-22.561134,"median":-14.507003,"eighty":-9.188871,"marketCap":633905185},{"date":"2022-04-22","current":-7.837556,"twenty":-22.538814,"median":-13.973512,"eighty":-9.036889,"marketCap":579649950},{"date":"2022-04-29","current":-6.838169,"twenty":-22.390692,"median":-13.618955,"eighty":-8.845017,"marketCap":505737328},{"date":"2022-05-06","current":-7.258497,"twenty":-21.982852,"median":-13.469842,"eighty":-8.788285,"marketCap":536823934},{"date":"2022-05-13","current":-4.44298,"twenty":-21.749509,"median":-13.340611,"eighty":-8.643231,"marketCap":380381257},{"date":"2022-05-20","current":-4.529778,"twenty":-21.495877,"median":-12.962859,"eighty":-8.557578,"marketCap":387812393},{"date":"2022-05-27","current":-4.394156,"twenty":-21.487505,"median":-12.757415,"eighty":-8.408627,"marketCap":376201243},{"date":"2022-06-03","current":-4.171735,"twenty":-21.486484,"median":-12.512208,"eighty":-8.317172,"marketCap":357158958},{"date":"2022-06-10","current":-3.987289,"twenty":-21.431086,"median":-12.276941,"eighty":-8.157328,"marketCap":341367795},{"date":"2022-06-17","current":-3.737745,"twenty":-21.027472,"median":-12.061556,"eighty":-7.988037,"marketCap":320003280},{"date":"2022-06-24","current":-5.555081,"twenty":-20.755231,"median":-11.829603,"eighty":-7.852775,"marketCap":475592683},{"date":"2022-07-01","current":-5.484557,"twenty":-20.623859,"median":-11.723567,"eighty":-7.615655,"marketCap":469554885},{"date":"2022-07-08","current":-6.363388,"twenty":-20.536805,"median":-11.610905,"eighty":-7.507923,"marketCap":544795134},{"date":"2022-07-15","current":-5.560506,"twenty":-20.357922,"median":-11.511496,"eighty":-7.294353,"marketCap":476057129},{"date":"2022-07-22","current":-5.734102,"twenty":-20.19119,"median":-11.289484,"eighty":-7.062104,"marketCap":490919400},{"date":"2022-07-29","current":-4.920369,"twenty":-20.125792,"median":-10.954809,"eighty":-6.568449,"marketCap":421252503},{"date":"2022-08-05","current":-5.028867,"twenty":-20.111745,"median":-10.573743,"eighty":-6.265809,"marketCap":430541423},{"date":"2022-08-12","current":-4.981337,"twenty":-20.061386,"median":-10.000488,"eighty":-5.808965,"marketCap":466641657},{"date":"2022-08-19","current":-4.469794,"twenty":-19.961267,"median":-9.920962,"eighty":-5.729762,"marketCap":418721328},{"date":"2022-08-26","current":-4.276103,"twenty":-19.799094,"median":-9.609481,"eighty":-5.558336,"marketCap":400576737},{"date":"2022-09-02","current":-4.007915,"twenty":-19.721664,"median":-9.539896,"eighty":-5.398844,"marketCap":375453457},{"date":"2022-09-09","current":-4.499592,"twenty":-19.67735,"median":-9.476937,"eighty":-5.213313,"marketCap":421512803},{"date":"2022-09-16","current":-3.560936,"twenty":-19.594646,"median":-9.417292,"eighty":-5.015848,"marketCap":333581324},{"date":"2022-09-23","current":-3.620533,"twenty":-19.561201,"median":-9.347706,"eighty":-4.926877,"marketCap":339164275},{"date":"2022-09-30","current":-4.057579,"twenty":-19.536362,"median":-9.251611,"eighty":-4.748116,"marketCap":380105916},{"date":"2022-10-07","current":-3.620533,"twenty":-19.508606,"median":-9.237245,"eighty":-4.620073,"marketCap":339164275},{"date":"2022-10-14","current":-3.858922,"twenty":-19.454426,"median":-9.145575,"eighty":-4.526566,"marketCap":361496079},{"date":"2022-10-21","current":-3.863888,"twenty":-19.397827,"median":-9.072676,"eighty":-4.487672,"marketCap":361961325},{"date":"2022-10-28","current":-4.310868,"twenty":-19.375413,"median":-8.933504,"eighty":-4.453706,"marketCap":403833458},{"date":"2022-11-04","current":-4.087378,"twenty":-19.315509,"median":-8.817726,"eighty":-4.438209,"marketCap":382897392},{"date":"2022-11-11","current":-4.3395,"twenty":-19.276083,"median":-8.790603,"eighty":-4.412183,"marketCap":438979437},{"date":"2022-11-18","current":-4.396913,"twenty":-19.219269,"median":-8.708993,"eighty":-4.412183,"marketCap":444787324},{"date":"2022-11-25","current":-4.057217,"twenty":-19.132862,"median":-8.645219,"eighty":-4.38315,"marketCap":410423994},{"date":"2022-12-02","current":-4.650489,"twenty":-19.117127,"median":-8.571151,"eighty":-4.316594,"marketCap":470438824},{"date":"2022-12-09","current":-4.105061,"twenty":-19.055674,"median":-8.542497,"eighty":-4.31181,"marketCap":415263900},{"date":"2022-12-16","current":-4.38256,"twenty":-18.968252,"median":-8.482853,"eighty":-4.31181,"marketCap":443335352},{"date":"2022-12-23","current":-3.798856,"twenty":-18.890912,"median":-8.331837,"eighty":-4.235803,"marketCap":384288504},{"date":"2022-12-30","current":-3.640969,"twenty":-18.860126,"median":-8.310544,"eighty":-4.205535,"marketCap":368316816},{"date":"2023-01-06","current":-3.808425,"twenty":-18.846594,"median":-8.213759,"eighty":-4.17065,"marketCap":385256485},{"date":"2023-01-13","current":-3.736658,"twenty":-18.811555,"median":-8.094628,"eighty":-4.139059,"marketCap":377996627},{"date":"2023-01-20","current":-3.478298,"twenty":-18.656441,"median":-7.994307,"eighty":-4.126116,"marketCap":351861137},{"date":"2023-01-27","current":-3.564418,"twenty":-18.496578,"median":-7.966092,"eighty":-4.102277,"marketCap":360572967},{"date":"2023-02-03","current":-3.928037,"twenty":-18.445929,"median":-7.837556,"eighty":-4.071715,"marketCap":397356249},{"date":"2023-02-10","current":-3.301273,"twenty":-18.211675,"median":-7.650069,"eighty":-4.050353,"marketCap":333953486},{"date":"2023-02-17","current":-3.301273,"twenty":-17.979003,"median":-7.52826,"eighty":-4.031089,"marketCap":333953486},{"date":"2023-02-24","current":-2.908948,"twenty":-17.903029,"median":-7.496892,"eighty":-4.008498,"marketCap":294266260},{"date":"2023-03-03","current":-3.021383,"twenty":-17.774822,"median":-7.375355,"eighty":-3.988467,"marketCap":305640038},{"date":"2023-03-10","current":-2.875457,"twenty":-17.562728,"median":-7.258497,"eighty":-3.954278,"marketCap":290878326},{"date":"2023-03-17","current":-3.27637,"twenty":-17.410779,"median":-7.049876,"eighty":-3.928452,"marketCap":355489421},{"date":"2023-03-24","current":-3.05855,"twenty":-17.307897,"median":-6.838169,"eighty":-3.917008,"marketCap":331855775},{"date":"2023-03-31","current":-3.535031,"twenty":-17.067312,"median":-6.444762,"eighty":-3.890707,"marketCap":383554375},{"date":"2023-04-06","current":-3.55772,"twenty":-16.760926,"median":-6.311852,"eighty":-3.859915,"marketCap":386016214},{"date":"2023-04-14","current":-3.435333,"twenty":-16.618439,"median":-6.010771,"eighty":-3.814987,"marketCap":372737057},{"date":"2023-04-21","current":-2.741005,"twenty":-16.300891,"median":-5.804626,"eighty":-3.783338,"marketCap":297401826},{"date":"2023-04-28","current":-2.056248,"twenty":-16.168282,"median":-5.744952,"eighty":-3.756614,"marketCap":223104955},{"date":"2023-05-05","current":-2.255972,"twenty":-15.843809,"median":-5.669003,"eighty":-3.725176,"marketCap":244775193},{"date":"2023-05-12","current":-2.470827,"twenty":-15.657039,"median":-5.560506,"eighty":-3.692043,"marketCap":288115670},{"date":"2023-05-19","current":-2.341989,"twenty":-15.495593,"median":-5.495407,"eighty":-3.672963,"marketCap":273092261},{"date":"2023-05-26","current":-2.587179,"twenty":-15.293051,"median":-5.310961,"eighty":-3.637142,"marketCap":301683147},{"date":"2023-06-02","current":-3.191699,"twenty":-15.242626,"median":-5.245862,"eighty":-3.620533,"marketCap":372174471},{"date":"2023-06-09","current":-2.79855,"twenty":-15.179034,"median":-5.148214,"eighty":-3.55772,"marketCap":326330463},{"date":"2023-06-16","current":-3.124061,"twenty":-15.13155,"median":-5.007168,"eighty":-3.535031,"marketCap":364287330},{"date":"2023-06-23","current":-2.883098,"twenty":-15.114375,"median":-4.963768,"eighty":-3.480838,"marketCap":336189390},{"date":"2023-06-30","current":-2.849279,"twenty":-14.768116,"median":-4.920369,"eighty":-3.448117,"marketCap":332245819},{"date":"2023-07-07","current":-2.675954,"twenty":-14.526885,"median":-4.860696,"eighty":-3.413944,"marketCap":312035020},{"date":"2023-07-14","current":-3.031057,"twenty":-14.335797,"median":-4.706086,"eighty":-3.350075,"marketCap":353442511},{"date":"2023-07-21","current":-2.942282,"twenty":-14.075236,"median":-4.650489,"eighty":-3.337601,"marketCap":343090638},{"date":"2023-07-28","current":-2.857733,"twenty":-13.99273,"median":-4.609544,"eighty":-3.286331,"marketCap":333231712},{"date":"2023-08-04","current":-2.840824,"twenty":-13.866813,"median":-4.549257,"eighty":-3.262997,"marketCap":331259927},{"date":"2023-08-11","current":-2.647103,"twenty":-13.758127,"median":-4.527101,"eighty":-3.237161,"marketCap":331724377},{"date":"2023-08-18","current":-2.528221,"twenty":-13.584493,"median":-4.519458,"eighty":-3.201703,"marketCap":316826576},{"date":"2023-08-25","current":-2.540109,"twenty":-13.53015,"median":-4.509347,"eighty":-3.178351,"marketCap":318316356},{"date":"2023-09-01","current":-2.326122,"twenty":-13.481109,"median":-4.499592,"eighty":-3.139233,"marketCap":291500314},{"date":"2023-09-08","current":-2.377638,"twenty":-13.408209,"median":-4.479726,"eighty":-3.120679,"marketCap":297956028},{"date":"2023-09-15","current":-2.389526,"twenty":-13.377724,"median":-4.469949,"eighty":-3.079513,"marketCap":299445808},{"date":"2023-09-22","current":-2.433116,"twenty":-13.274339,"median":-4.44298,"eighty":-3.053696,"marketCap":304908335},{"date":"2023-09-29","current":-1.894185,"twenty":-13.001297,"median":-4.435109,"eighty":-3.040423,"marketCap":237371635},{"date":"2023-10-06","current":-1.803042,"twenty":-12.966835,"median":-4.43213,"eighty":-3.021861,"marketCap":225949987},{"date":"2023-10-13","current":-1.886259,"twenty":-12.935025,"median":-4.415163,"eighty":-2.989629,"marketCap":236378448},{"date":"2023-10-20","current":-1.238353,"twenty":-12.83164,"median":-4.394156,"eighty":-2.968346,"marketCap":155185431},{"date":"2023-10-27","current":-0.990682,"twenty":-12.794527,"median":-4.38256,"eighty":-2.963419,"marketCap":124148345},{"date":"2023-11-03","current":-1.375067,"twenty":-12.72958,"median":-4.364906,"eighty":-2.947224,"marketCap":172317902},{"date":"2023-11-10","current":-1.233243,"twenty":-12.591734,"median":-4.320362,"eighty":-2.929599,"marketCap":163875815},{"date":"2023-11-17","current":-1.220627,"twenty":-12.388942,"median":-4.300975,"eighty":-2.908754,"marketCap":162199376},{"date":"2023-11-24","current":-1.118908,"twenty":-12.298811,"median":-4.264741,"eighty":-2.899162,"marketCap":148682761},{"date":"2023-12-01","current":-1.167884,"twenty":-12.278929,"median":-4.220559,"eighty":-2.874969,"marketCap":155190761},{"date":"2023-12-08","current":-1.382624,"twenty":-12.216633,"median":-4.202198,"eighty":-2.852661,"marketCap":183725837},{"date":"2023-12-15","current":-1.876149,"twenty":-12.109272,"median":-4.171735,"eighty":-2.835751,"marketCap":249306449},{"date":"2023-12-21","current":-2.034379,"twenty":-12.033722,"median":-4.161875,"eighty":-2.801932,"marketCap":270332294},{"date":"2023-12-29","current":-2.234049,"twenty":-11.950218,"median":-4.147323,"eighty":-2.779949,"marketCap":296864908},{"date":"2024-01-05","current":-2.29056,"twenty":-11.885272,"median":-4.138553,"eighty":-2.745422,"marketCap":304374138},{"date":"2024-01-12","current":-2.320699,"twenty":-11.829603,"median":-4.124626,"eighty":-2.696246,"marketCap":308379061},{"date":"2024-01-19","current":-1.928892,"twenty":-11.813698,"median":-4.108636,"eighty":-2.660736,"marketCap":256315064},{"date":"2024-01-26","current":-2.181306,"twenty":-11.739472,"median":-4.102277,"eighty":-2.626219,"marketCap":289856293},{"date":"2024-02-02","current":-1.864847,"twenty":-11.683804,"median":-4.084259,"eighty":-2.589287,"marketCap":247804603},{"date":"2024-02-09","current":-1.766895,"twenty":-11.622833,"median":-4.057217,"eighty":-2.544864,"marketCap":234788603},{"date":"2024-02-16","current":-2.083354,"twenty":-11.580419,"median":-4.049788,"eighty":-2.51554,"marketCap":276840294},{"date":"2024-02-23","current":-2.117261,"twenty":-11.538005,"median":-4.038079,"eighty":-2.488594,"marketCap":281345832},{"date":"2024-03-01","current":-2.384744,"twenty":-11.511496,"median":-4.027781,"eighty":-2.470827,"marketCap":316889522},{"date":"2024-03-08","current":-2.215212,"twenty":-11.345815,"median":-4.008643,"eighty":-2.445485,"marketCap":294361831},{"date":"2024-03-15","current":-2.255961,"twenty":-11.299425,"median":-4.002949,"eighty":-2.409339,"marketCap":305348805},{"date":"2024-03-22","current":-2.811616,"twenty":-11.279543,"median":-3.985186,"eighty":-2.409339,"marketCap":380557871},{"date":"2024-03-28","current":-2.607876,"twenty":-11.189413,"median":-3.968184,"eighty":-2.428361,"marketCap":352981214},{"date":"2024-04-05","current":-2.604171,"twenty":-10.997223,"median":-3.938385,"eighty":-2.439456,"marketCap":352479820},{"date":"2024-04-12","current":-2.656033,"twenty":-10.9283,"median":-3.928452,"eighty":-2.441151,"marketCap":359499333},{"date":"2024-04-19","current":-2.192987,"twenty":-10.815637,"median":-3.927616,"eighty":-2.428361,"marketCap":296825111},{"date":"2024-04-26","current":-2.018881,"twenty":-10.444512,"median":-3.908587,"eighty":-2.396254,"marketCap":273259604},{"date":"2024-05-03","current":-2.081532,"twenty":-10.103872,"median":-3.893687,"eighty":-2.391269,"marketCap":281739516},{"date":"2024-05-10","current":-1.926413,"twenty":-10.008441,"median":-3.873821,"eighty":-2.384115,"marketCap":260609053},{"date":"2024-05-17","current":-2.359171,"twenty":-9.995186,"median":-3.853955,"eighty":-2.378352,"marketCap":319153357},{"date":"2024-05-24","current":-1.803274,"twenty":-9.951447,"median":-3.819703,"eighty":-2.372696,"marketCap":243950555},{"date":"2024-05-31","current":-1.862028,"twenty":-9.916985,"median":-3.806358,"eighty":-2.368104,"marketCap":251898818},{"date":"2024-06-07","current":-1.798755,"twenty":-9.793718,"median":-3.779459,"eighty":-2.355212,"marketCap":243339150},{"date":"2024-06-14","current":-1.730963,"twenty":-9.654546,"median":-3.767355,"eighty":-2.335642,"marketCap":234168076},{"date":"2024-06-21","current":-1.640573,"twenty":-9.604179,"median":-3.746186,"eighty":-2.315484,"marketCap":221939978},{"date":"2024-06-28","current":-1.690287,"twenty":-9.588274,"median":-3.736658,"eighty":-2.260797,"marketCap":228665432},{"date":"2024-07-05","current":-1.645092,"twenty":-9.561765,"median":-3.714895,"eighty":-2.253501,"marketCap":222551383},{"date":"2024-07-12","current":-1.952417,"twenty":-9.500795,"median":-3.696127,"eighty":-2.234668,"marketCap":264126916},{"date":"2024-07-19","current":-1.9253,"twenty":-9.484889,"median":-3.688814,"eighty":-2.215212,"marketCap":260458487},{"date":"2024-07-26","current":-2.110599,"twenty":-9.463682,"median":-3.667714,"eighty":-2.183642,"marketCap":285526088},{"date":"2024-08-02","current":-1.812313,"twenty":-9.454404,"median":-3.640969,"eighty":-2.154934,"marketCap":245173364},{"date":"2024-08-09","current":-1.854003,"twenty":-9.413593,"median":-3.620892,"eighty":-2.14125,"marketCap":241787985},{"date":"2024-08-16","current":-2.202217,"twenty":-9.393218,"median":-3.593125,"eighty":-2.132558,"marketCap":287199942},{"date":"2024-08-23","current":-2.97864,"twenty":-9.361623,"median":-3.559328,"eighty":-2.14125,"marketCap":388456331},{"date":"2024-08-30","current":-2.90335,"twenty":-9.311256,"median":-3.540496,"eighty":-2.143496,"marketCap":378637530},{"date":"2024-09-06","current":-2.677482,"twenty":-9.258238,"median":-3.535031,"eighty":-2.148534,"marketCap":349181126},{"date":"2024-09-13","current":-2.861,"twenty":-9.251611,"median":-3.491846,"eighty":-2.151167,"marketCap":373114454},{"date":"2024-09-20","current":-3.049224,"twenty":-9.244984,"median":-3.45916,"eighty":-2.154934,"marketCap":397661458},{"date":"2024-09-27","current":-2.432791,"twenty":-9.244984,"median":-3.428109,"eighty":-2.154934,"marketCap":317270021},{"date":"2024-10-04","current":-2.395146,"twenty":-9.229506,"median":-3.412507,"eighty":-2.162469,"marketCap":312360620},{"date":"2024-10-11","current":-2.319857,"twenty":-9.178712,"median":-3.381127,"eighty":-2.167056,"marketCap":302541819},{"date":"2024-10-18","current":-2.597487,"twenty":-9.145575,"median":-3.339901,"eighty":-2.181306,"marketCap":338748649},{"date":"2024-10-25","current":-2.301035,"twenty":-9.145575,"median":-3.337926,"eighty":-2.192987,"marketCap":300087119},{"date":"2024-11-01","current":-4.187977,"twenty":-9.132321,"median":-3.339901,"eighty":-2.200989,"marketCap":546170830},{"date":"2024-11-08","current":-4.765082,"twenty":-9.013031,"median":-3.381127,"eighty":-2.202217,"marketCap":568898434},{"date":"2024-11-15","current":-3.982909,"twenty":-8.986522,"median":-3.412507,"eighty":-2.207911,"marketCap":475515537},{"date":"2024-11-22","current":-4.36885,"twenty":-8.933504,"median":-3.428109,"eighty":-2.215212,"marketCap":521592624},{"date":"2024-11-29","current":-5.331129,"twenty":-8.896392,"median":-3.4579,"eighty":-2.215212,"marketCap":636478161},{"date":"2024-12-06","current":-4.842271,"twenty":-8.845017,"median":-3.481473,"eighty":-2.224686,"marketCap":578113851},{"date":"2024-12-13","current":-3.890283,"twenty":-8.807667,"median":-3.533084,"eighty":-2.2284,"marketCap":464457036},{"date":"2024-12-20","current":-3.566093,"twenty":-8.795658,"median":-3.535031,"eighty":-2.232987,"marketCap":425752283},{"date":"2024-12-27","current":-3.632989,"twenty":-8.792095,"median":-3.554849,"eighty":-2.235907,"marketCap":433738978},{"date":"2025-01-03","current":-3.689594,"twenty":-8.789444,"median":-3.560936,"eighty":-2.240226,"marketCap":440496951},{"date":"2025-01-10","current":-2.93315,"twenty":-8.774451,"median":-3.554849,"eighty":-2.244949,"marketCap":350185861},{"date":"2025-01-17","current":-2.909994,"twenty":-8.716457,"median":-3.537764,"eighty":-2.246858,"marketCap":347421235},{"date":"2025-01-24","current":-2.840524,"twenty":-8.696552,"median":-3.533084,"eighty":-2.252886,"marketCap":339127360},{"date":"2025-01-31","current":-3.427154,"twenty":-8.648533,"median":-3.481473,"eighty":-2.255961,"marketCap":409164532},{"date":"2025-02-07","current":-3.468321,"twenty":-8.641906,"median":-3.479885,"eighty":-2.255972,"marketCap":414079421},{"date":"2025-02-14","current":-3.488905,"twenty":-8.615397,"median":-3.468321,"eighty":-2.258537,"marketCap":416536866},{"date":"2025-02-21","current":-3.200736,"twenty":-8.58,"median":-3.45803,"eighty":-2.258655,"marketCap":382132641},{"date":"2025-02-28","current":-2.830233,"twenty":-8.566135,"median":-3.433816,"eighty":-2.263087,"marketCap":337898638},{"date":"2025-03-07","current":-3.288216,"twenty":-8.557578,"median":-3.420884,"eighty":-2.267314,"marketCap":392576781},{"date":"2025-03-14","current":-3.226465,"twenty":-8.534545,"median":-3.414303,"eighty":-2.275625,"marketCap":385204447},{"date":"2025-03-21","current":-4.907248,"twenty":-8.502577,"median":-3.420884,"eighty":-2.277507,"marketCap":356756961},{"date":"2025-03-28","current":-4.314994,"twenty":-8.485464,"median":-3.4323,"eighty":-2.287949,"marketCap":313700087},{"date":"2025-04-04","current":-3.342005,"twenty":-8.408627,"median":-3.4323,"eighty":-2.29056,"marketCap":242963792},{"date":"2025-04-11","current":-3.570446,"twenty":-8.347657,"median":-3.433687,"eighty":-2.29141,"marketCap":259571444},{"date":"2025-04-17","current":-3.849652,"twenty":-8.330793,"median":-3.441536,"eighty":-2.291623,"marketCap":279869685},{"date":"2025-04-25","current":-4.281151,"twenty":-8.320951,"median":-3.45803,"eighty":-2.29727,"marketCap":311239694},{"date":"2025-05-02","current":-4.205004,"twenty":-8.309219,"median":-3.465749,"eighty":-2.303858,"marketCap":305703810},{"date":"2025-05-09","current":40.886587,"twenty":-8.268632,"median":-3.463176,"eighty":-2.29727,"marketCap":251575167},{"date":"2025-05-16","current":39.786947,"twenty":-8.207488,"median":-3.457335,"eighty":-2.285339,"marketCap":244809087},{"date":"2025-05-23","current":40.486718,"twenty":-8.16736,"median":-3.435333,"eighty":-2.261986,"marketCap":249114775},{"date":"2025-05-30","current":42.286127,"twenty":-8.132248,"median":-3.4323,"eighty":-2.255965,"marketCap":260186542},{"date":"2025-06-06","current":46.184849,"twenty":-8.07958,"median":-3.428999,"eighty":-2.240226,"marketCap":284175373},{"date":"2025-06-13","current":49.183865,"twenty":-8.031927,"median":-3.416863,"eighty":-2.219949,"marketCap":302628319},{"date":"2025-06-20","current":44.885275,"twenty":-7.993053,"median":-3.412507,"eighty":-2.203356,"marketCap":276179096},{"date":"2025-06-27","current":46.584717,"twenty":-7.986783,"median":-3.411516,"eighty":-2.169906,"marketCap":286635765},{"date":"2025-07-03","current":48.684029,"twenty":-7.981767,"median":-3.387058,"eighty":-2.154934,"marketCap":299552828},{"date":"2025-07-11","current":52.58275,"twenty":-7.950417,"median":-3.357685,"eighty":-2.141004,"marketCap":323541658},{"date":"2025-07-18","current":58.980651,"twenty":-7.85658,"median":-3.347149,"eighty":-2.117261,"marketCap":362907943},{"date":"2025-07-25","current":57.081274,"twenty":-7.837556,"median":-3.339901,"eighty":-2.110599,"marketCap":351221077},{"date":"2025-08-01","current":49.483766,"twenty":-7.714094,"median":-3.337926,"eighty":-2.090889,"marketCap":304473613},{"date":"2025-08-08","current":10.809419,"twenty":-7.678825,"median":-3.319091,"eighty":-2.081532,"marketCap":261242050},{"date":"2025-08-15","current":11.11607,"twenty":-7.621313,"median":-3.301273,"eighty":-2.068285,"marketCap":268653172},{"date":"2025-08-22","current":11.499382,"twenty":-7.593024,"median":-3.291241,"eighty":-2.06075,"marketCap":277917075},{"date":"2025-08-29","current":12.34267,"twenty":-7.52826,"median":-3.278084,"eighty":-2.042807,"marketCap":298297660},{"date":"2025-09-05","current":12.547104,"twenty":-7.517874,"median":-3.270174,"eighty":-2.025978,"marketCap":303238408},{"date":"2025-09-12","current":12.495996,"twenty":-7.500569,"median":-3.262997,"eighty":-2.002356,"marketCap":302003221},{"date":"2025-09-19","current":17.709049,"twenty":-7.471798,"median":-3.255413,"eighty":-1.983516,"marketCap":427992295},{"date":"2025-09-26","current":16.73799,"twenty":-7.441705,"median":-3.247049,"eighty":-1.976967,"marketCap":404523742},{"date":"2025-10-03","current":19.497842,"twenty":-7.339117,"median":-3.227985,"eighty":-1.950149,"marketCap":471223840},{"date":"2025-10-10","current":21.618839,"twenty":-7.273746,"median":-3.212836,"eighty":-1.928396,"marketCap":522484101},{"date":"2025-10-17","current":26.346363,"twenty":-7.259486,"median":-3.205552,"eighty":-1.908585,"marketCap":636738898},{"date":"2025-10-24","current":26.525242,"twenty":-7.230643,"median":-3.19559,"eighty":-1.894081,"marketCap":641062053},{"date":"2025-10-31","current":33.245992,"twenty":-7.133549,"median":-3.183443,"eighty":-1.885744,"marketCap":803489143},{"date":"2025-11-07","current":40.446007,"twenty":-7.013191,"median":-3.176536,"eighty":-1.876311,"marketCap":847182070},{"date":"2025-11-14","current":44.518588,"twenty":-6.890394,"median":-3.151132,"eighty":-1.866206,"marketCap":932486337},{"date":"2025-11-21","current":42.031516,"twenty":-6.843697,"median":-3.144131,"eighty":-1.859665,"marketCap":880392128},{"date":"2025-11-28","current":50.269942,"twenty":-6.693262,"median":-3.132515,"eighty":-1.842692,"marketCap":1052954195},{"date":"2025-12-05","current":53.658577,"twenty":-6.554344,"median":-3.121947,"eighty":-1.815025,"marketCap":1123932554},{"date":"2025-12-12","current":51.482389,"twenty":-6.428487,"median":-3.111378,"eighty":-1.809448,"marketCap":1078350122},{"date":"2025-12-19","current":49.212936,"twenty":-6.340604,"median":-3.096861,"eighty":-1.801327,"marketCap":1030814156},{"date":"2025-12-26","current":54.839936,"twenty":-6.314564,"median":-3.082381,"eighty":-1.791999,"marketCap":1148677304},{"date":"2026-01-02","current":48.74661,"twenty":-6.28205,"median":-3.074727,"eighty":-1.778694,"marketCap":1021046492},{"date":"2026-01-09","current":78.684738,"twenty":-6.175825,"median":-3.066835,"eighty":-1.762599,"marketCap":1648130530},{"date":"2026-01-16","current":91.047649,"twenty":-6.003278,"median":-3.052338,"eighty":-1.746551,"marketCap":1907084059},{"date":"2026-01-23","current":87.039738,"twenty":-5.973306,"median":-3.046482,"eighty":-1.721924,"marketCap":1823134345},{"date":"2026-01-30","current":80.763197,"twenty":-5.909684,"median":-3.040399,"eighty":-1.680197,"marketCap":1691665926},{"date":"2026-02-06","current":71.461818,"twenty":-5.826325,"median":-3.027416,"eighty":-1.640573,"marketCap":1496839232},{"date":"2026-02-13","current":69.949398,"twenty":-5.782926,"median":-3.010338,"eighty":-1.608936,"marketCap":1465160095},{"date":"2026-02-20","current":72.44489,"twenty":-5.769906,"median":-3.006873,"eighty":-1.587702,"marketCap":1517430671},{"date":"2026-02-27","current":69.949398,"twenty":-5.749292,"median":-2.993956,"eighty":-1.402693,"marketCap":1465160095},{"date":"2026-03-06","current":67.869821,"twenty":-5.736272,"median":-2.992757,"eighty":-1.371897,"marketCap":1421601281},{"date":"2026-03-13","current":60.648019,"twenty":-5.725422,"median":-2.979484,"eighty":-1.309435,"marketCap":1270333401},{"date":"2026-03-20","current":-33.269083,"twenty":-5.749292,"median":-2.980328,"eighty":-1.280151,"marketCap":1285051612},{"date":"2026-03-27","current":-32.461179,"twenty":-5.922408,"median":-2.992884,"eighty":-1.309435,"marketCap":1253845501},{"date":"2026-04-02","current":-35.568503,"twenty":-6.249569,"median":-2.993956,"eighty":-1.334647,"marketCap":1373869002},{"date":"2026-04-10","current":-37.391467,"twenty":-6.554344,"median":-3.006873,"eighty":-1.352083,"marketCap":1444282789},{"date":"2026-04-17","current":-38.737974,"twenty":-7.037647,"median":-3.015861,"eighty":-1.357631,"marketCap":1496292972},{"date":"2026-04-24","current":-41.783151,"twenty":-7.284049,"median":-3.031057,"eighty":-1.368727,"marketCap":1613916003},{"date":"2026-05-01","current":-39.670171,"twenty":-7.504246,"median":-3.040459,"eighty":-1.377421,"marketCap":1532300023},{"date":"2026-05-08","current":-12.847947,"twenty":-7.644318,"median":-3.049224,"eighty":-1.38117,"marketCap":1670412976},{"date":"2026-05-15","current":-12.137735,"twenty":-7.894115,"median":-3.055516,"eighty":-1.384884,"marketCap":1578075528},{"date":"2026-05-22","current":-12.26769,"twenty":-8.019387,"median":-3.072164,"eighty":-1.398618,"marketCap":1594971411},{"date":"2026-05-29","current":-12.599073,"twenty":-8.172376,"median":-3.076702,"eighty":-1.411524,"marketCap":1638055915},{"date":"2026-06-05","current":-11.280037,"twenty":-8.32284,"median":-3.086569,"eighty":-1.462229,"marketCap":1466562696},{"date":"2026-06-12","current":-11.111096,"twenty":-8.490687,"median":-3.108591,"eighty":-1.549469,"marketCap":1444598047},{"date":"2026-06-18","current":-11.962297,"twenty":-8.563055,"median":-3.118402,"eighty":-1.583646,"marketCap":1555266085},{"date":"2026-06-26","current":-14.074055,"twenty":-8.568643,"median":-3.119117,"eighty":-1.584998,"marketCap":1829824193},{"date":"2026-07-02","current":-15.607516,"twenty":-8.568643,"median":-3.119117,"eighty":-1.584998,"marketCap":2029195620},{"date":"2026-07-10","current":-15.932402,"twenty":-8.568643,"median":-3.119117,"eighty":-1.584998,"marketCap":2071435329},{"date":"2026-07-17","current":-15.048713,"twenty":-8.568643,"median":-3.119117,"eighty":-1.584998,"marketCap":1956543320},{"date":"2026-07-24","current":-14.964242,"twenty":-8.568643,"median":-3.119117,"eighty":-1.584998,"marketCap":1945560996},{"date":"2026-07-31","current":-14.736822,"twenty":-8.563055,"median":-3.118402,"eighty":-1.583646,"marketCap":1915993200},{"date":"2026-08-07","current":-8.237367,"twenty":-8.55045,"median":-3.118402,"eighty":-1.583646,"marketCap":1327171656},{"date":"2026-08-14","current":-8.387524,"twenty":-8.404977,"median":-3.118402,"eighty":-1.583646,"marketCap":1351364271},{"date":"2026-08-21","current":-7.826237,"twenty":-8.34354,"median":-3.118402,"eighty":-1.583646,"marketCap":1260932066},{"date":"2026-08-28","current":-7.58266,"twenty":-8.243561,"median":-3.118402,"eighty":-1.583646,"marketCap":1221687902}],"updateTime":1788100050013},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLUE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662076530","title":"Monte Rosa Therapeutics (GLUE) Looks Pricey As Phase 2 Progress Keeps The Story Alive","url":"https://stock-news.laohu8.com/highlight/detail?id=2662076530","media":"Simply Wall St.","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662076530?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:24","pubTimestamp":1787700269,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics (GLUE) dosed the first patient in its MODeFIRe-1 Phase 2 trial of MRT-2359 with apalutamide for AR mutation-positive metastatic castration-resistant prostate cancer, building on earlier combination data with enzalutamide.\nSee our latest analysis for Monte Rosa Therapeutics.\nThe MRT-2359 update comes after a sharp 36.08% decline in the 30-day share price return and a 24.05% decline over 90 days, even as the 1-year total shareholder return of 211.78% and 3-year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-glue/monte-rosa-therapeutics/news/monte-rosa-therapeutics-glue-looks-pricey-as-phase-2-progres","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-glue/monte-rosa-therapeutics/news/monte-rosa-therapeutics-glue-looks-pricey-as-phase-2-progres","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GLUE","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732467","title":"Monte Rosa Therapeutics Price Target Maintained with a $28.00/Share by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732467","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732467?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:41","pubTimestamp":1787661660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GLUE/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662736083","title":"Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Rhythm Pharmaceuticals (RYTM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662736083","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662736083?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:50","pubTimestamp":1787655028,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Monte Rosa Therapeutics (GLUE) and Rhythm Pharmaceut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-and-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-and-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0029874061.USD","LABU","RYTM","GLUE","BK4137","BK4588","XLV","XBI","MEDI","BK4539","HCSG","BK4581","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661517273","title":"Monte Rosa Doses First Patient in Phase 2 MODeFIRe-1 Trial of MRT-2359 Plus Apalutamide in mCRPC","url":"https://stock-news.laohu8.com/highlight/detail?id=2661517273","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661517273?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:02","pubTimestamp":1787569332,"startTime":"0","endTime":"0","summary":"Monte Rosa doses first patient in Phase 2 MODeFIRe-1 trial of MRT-2359 plus apalutamide in mCRPCMonte Rosa Therapeutics dosed the first patient in MODeFIRe-1, a Phase 2 trial of MRT-2359 with apalutam","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL4FK4J5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SG9999014005.SGD","IE00BN0W2T93.GBP","BK4539","LU2095319765.USD","IE00BKPKM429.USD","LU2210149790.SGD","LU2210150020.SGD","BCDF","IE00BQXX3F31.USD","SG9999014013.SGD","BK4588","SG9999014021.USD","GLUE","IE00BGHQF748.EUR","IE00BN0W2W23.USD","SG9999014039.USD","IE00B64PRP62.GBP","LU0314104364.USD","BK4112","IE00BQXX3D17.EUR","IE00B3QW5Z07.USD","NDAQ","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273874","title":"Monte Rosa Therapeutics Announces First Patient Dosed in Modefire-1, a Phase 2 Study of Mrt-2359 in Combination with Apalutamide in Patients with Ar Mutation-Positive Metastatic Castration-Resistant Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273874","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273874?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA1XLBHX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLUE","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273674","title":"Monte Rosa Therapeutics - to Provide Phase 1/2 Study Update on Mrt-2359 Plus Enzalutamide by Year-End","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273674","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273674?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA1XLBHX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GLUE","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660170137","title":"Widening Losses And Profitability Swing Might Change The Case For Investing In Monte Rosa Therapeutics (GLUE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660170137","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660170137?lang=en_us&edition=fundamental","pubTime":"2026-08-17 00:23","pubTimestamp":1786897401,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics, Inc. reported past earnings for the second quarter and first half of 2026, with net loss widening to US$43.4 million for the quarter and US$87.9 million for the six-month period, alongside basic and diluted loss per share of US$0.43 and US$0.87 respectively from continuing operations.\nAn important insight is the swing from prior-year profitability over the first half of the year to a loss, marking a clear shift in the company’s recent financial profile.\nWe will now...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-glue/monte-rosa-therapeutics/news/widening-losses-and-profitability-swing-might-change-the-cas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-glue/monte-rosa-therapeutics/news/widening-losses-and-profitability-swing-might-change-the-cas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GLUE","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659315159","title":"Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659315159","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659315159?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:10","pubTimestamp":1786619422,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Monte Rosa Therapeutics (GLUE), Mineralys Therapeuti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-mineralys-therapeutics-inc-mlys-and-adagene-adag-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-mineralys-therapeutics-inc-mlys-and-adagene-adag-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0128526141.USD","BK4539","HCSG","BK4139","XBI","GLUE","BK4581","ADAG","BK4137","LABU","BK4588","MLYS","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657464160","title":"Monte Rosa Therapeutics is Maintained at Overweight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2657464160","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657464160?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:56","pubTimestamp":1786110960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GLUE/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657610434","title":"Gyre Therapeutics Q2 Revenue Beats Estimates on Higher Etuary Sales Volumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2657610434","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657610434?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:13","pubTimestamp":1786101215,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumesOverviewUS-China biopharma firm's Q2 revenue fell yr/yr but beat analyst expectationsCompany reported Q2 GAAP net loss widene","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL1N4440CX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0057025933.USD","BK4567","LU0689626769.HKD","LU0472753341.HKD","ZNTL","IE000M9KFDE8.USD","BK4533","LU0289961442.SGD","MADE","LU0203345920.USD","LU0203347892.USD","BK4588","LU0154245673.USD","LU0069063385.USD","LU0154245756.USD","LU2463526074.USD","LU0124676726.USD","LU0289739343.SGD","BK4585","BK4139","LU0511384066.AUD","GYRE","BK4539","GLUE","BK4149","CMI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657668017","title":"Relay Therapeutics Q2 Revenue Misses Estimates on Higher R&D Expenses; Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2657668017","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657668017?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:40","pubTimestamp":1786048849,"startTime":"0","endTime":"0","summary":"Relay Therapeutics Q2 revenue misses estimates on higher R&D expenses; net loss widensOverviewUS precision medicine developer's Q2 revenue declined and missed analyst expectationsNet loss for Q2 widen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431FA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","RLAY","GLUE","CMPX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657630275","title":"Monte Rosa Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657630275","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657630275?lang=en_us&edition=fundamental","pubTime":"2026-08-06 22:32","pubTimestamp":1786026758,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings SummaryMonte Rosa Therapeutics, Inc.GLUE.OQreported a quarterly adjusted loss of 43 cents per share for the quart","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4432BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657635472","title":"Monte Rosa Therapeutics Q2 EPS $(0.43) Misses $(0.38) Estimate, Sales $8.968M Beat $5.524M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657635472","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657635472?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:42","pubTimestamp":1786016579,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics (NASDAQ:GLUE) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.38) by 13.16 percent. This is a 186.67 percent decrease over losses of $(0.15) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60990131/monte-rosa-therapeutics-q2-eps-0-43-misses-0-38-estimate-sales-8-968m-beat-5-524m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657633979","title":"Monte Rosa Publishes Corporate Presentation on Targeted Protein Degradation Pipeline and Molecular Glue Degraders","url":"https://stock-news.laohu8.com/highlight/detail?id=2657633979","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657633979?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:25","pubTimestamp":1786015513,"startTime":"0","endTime":"0","summary":"Monte Rosa publishes corporate presentation on targeted protein degradation pipeline and molecular glue degradersMonte Rosa highlighted three clinical molecular glue degrader programs with Phase 2 tri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL6bK8Pf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","GLUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657633620","title":"Monte Rosa Activates Phase 2 MODeFIRe-1 Trial of MRT-2359 Plus Apalutamide in Metastatic Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2657633620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657633620?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:23","pubTimestamp":1786015386,"startTime":"0","endTime":"0","summary":"Monte Rosa activates Phase 2 MODeFIRe-1 trial of MRT-2359 plus apalutamide in metastatic prostate cancerMonte Rosa Therapeutics completed enrollment and dosing in its GFORCE-1 Phase 1 study of MRT-810","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL4Q46sB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","GLUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638713","title":"Monte Rosa Q2 FY26 Net Loss Widens to $43.4 Million; Revenue Falls 61.3% to $9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638713","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638713?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:14","pubTimestamp":1786014874,"startTime":"0","endTime":"0","summary":"Monte Rosa Q2 FY26 net loss widens to $43.4 million; revenue falls 61.3% to $9 millionMonte Rosa Therapeutics posted a net loss of $43.4 million in Q2 2026, widening from a $12.3 million loss a year e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL2pKP5V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","GLUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657368043","title":"Monte Rosa Therapeutics Q2 Operating Expenses USD 58.098 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657368043","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657368043?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXX9Z77D:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","GLUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657568321","title":"Monte Rosa’s MODeFIRe-1 Trial Pushes GLUE Into a Key Mid-Stage Prostate Cancer Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2657568321","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657568321?lang=en_us&edition=fundamental","pubTime":"2026-08-05 00:31","pubTimestamp":1785861074,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics, Inc. ($GLUE) announced an update on their ongoing clinical study. Monte Rosa Therapeutics, Inc. is running a Phase 2 study...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/monte-rosas-modefire-1-trial-pushes-glue-into-a-key-mid-stage-prostate-cancer-test?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/monte-rosas-modefire-1-trial-pushes-glue-into-a-key-mid-stage-prostate-cancer-test?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","GLUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656746413","title":"Monte Rosa Therapeutics is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2656746413","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656746413?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:29","pubTimestamp":1785763740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GLUE/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656395746","title":"Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2656395746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656395746?lang=en_us&edition=fundamental","pubTime":"2026-08-01 02:50","pubTimestamp":1785523843,"startTime":"0","endTime":"0","summary":"Monte Rosa Therapeutics (GLUE) is trading lower after Novo Nordisk’s (NVO) ZEUS trial failed to show a cardiovascular benefit for IL 6 inhibition, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/monte-rosa-bioage-sink-following-novo-nordisks-zeus-setback-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/monte-rosa-bioage-sink-following-novo-nordisks-zeus-setback-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4007","GLUE","NVOX","IE00BKVL7J92.USD","LU0154236417.USD","THNR","NVOH","NVO","BK4585","IE00BZ1G4Q59.USD","BK4139","BK4539","LU1093756325.SGD","BIOA","BK4588","LU1093756168.USD","OZEM","BK4599","PPH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":96,"code":"91000000","status":"200"}]}}